Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.
暂无分享,去创建一个
R. Thomas | G. Botti | G. D'aiuto | I. Capasso | G. Comella | V. de Rosa | P. Comella | G. Frasci | G. D’aiuto | G. Cortino